Related Experiment Videos
Experts' perspectives on SwissDRG: Second class care for vulnerable patient groups?
1Kalaidos University of Applied Sciences, Department Health Sciences, Careum Research, Zürich, Switzerland; Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
Health Policy (Amsterdam, Netherlands)
|March 24, 2018
Summary
Switzerland
Area of Science:
- Health Services Research
- Hospital Management
- Healthcare Policy
Background:
- Switzerland implemented the diagnosis-related group hospital tariff structure (SwissDRG) in 2012.
- Vulnerable patient groups were identified as a potential challenge for the new SwissDRG system.
- Ensuring equitable healthcare access for all patient populations is a key healthcare policy objective.
Purpose of the Study:
- To explore Swiss hospital experts' perceptions of vulnerable patient groups under SwissDRG.
- To understand changes in care for these groups post-SwissDRG implementation.
- To identify expert-proposed solutions for safeguarding vulnerable patients' healthcare access.
Main Methods:
- Qualitative study involving interviews with 43 healthcare experts from 40 Swiss hospitals.
- Exploration of expert opinions on patient vulnerability, system challenges, and mitigation strategies.
- Analysis of macro, meso, and micro-level measures for protecting vulnerable patient groups.
Main Results:
- Experts identified vulnerable groups as those less financially profitable under SwissDRG, citing concerns about system practicability and care complexity.
- Reported macro, meso, and micro-level measures aim to mitigate negative impacts on vulnerable patients.
- Introduced acute and transitional care (ATC) measures did not fully achieve their intended effect.
Conclusions:
- The SwissDRG system presents challenges for financially less profitable patient groups.
- Current mitigation strategies, including ATC measures, may be insufficient to guarantee adequate healthcare access for vulnerable populations.
- Further health data analysis is crucial to pinpoint specific risks and improve access for vulnerable patients in Switzerland.